<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="other">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosgen</journal-id>
<journal-title-group>
<journal-title>PLOS Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7390</issn>
<issn pub-type="epub">1553-7404</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PGENETICS-D-14-03278</article-id>
<article-id pub-id-type="doi">10.1371/journal.pgen.1004952</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Perspective</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Polyubiquitin Chain Reaction: Parkin Recruitment to Damaged Mitochondria</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Riley</surname> <given-names>Brigit E.</given-names></name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Olzmann</surname> <given-names>James A.</given-names></name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001">
<label>1</label>
<addr-line>Sangamo BioSciences Inc., Richmond, California, United States of America</addr-line>
</aff>
<aff id="aff002">
<label>2</label>
<addr-line>Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California, United States of America</addr-line>
</aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Lu</surname> <given-names>Bingwei</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>Stanford University School of Medicine, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">brigitriley@gmail.com</email> (BER); <email xlink:type="simple">olzmann@berkeley.edu</email> (JAO)</corresp>
</author-notes>
<pub-date pub-type="collection">
<month>1</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>1</month>
<year>2015</year>
</pub-date>
<volume>11</volume>
<issue>1</issue>
<elocation-id>e1004952</elocation-id>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Riley, Olzmann</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pgen.1004952" xlink:type="simple"/>
<related-article id="related001" related-article-type="companion" ext-link-type="uri" xlink:type="simple" xlink:href="pgen.1004861">
<article-title>Phosphorylation of Mitochondrial Polyubiquitin by PINK1 Promotes Parkin Mitochondrial Tethering</article-title>
</related-article>
<funding-group>
<funding-statement>This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R00DK095921) and the National Institute of General Medical Sciences (R01GM112948) to JAO. The funder had no role in the preparation of the article.</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<page-count count="4"/>
</counts>
</article-meta>
</front>
<body>
<p>Mutations in the E3 ubiquitin ligase Parkin or the mitochondrial kinase PINK1 cause autosomal recessive forms of Parkinson’s disease [<xref ref-type="bibr" rid="pgen.1004952.ref001">1</xref>, <xref ref-type="bibr" rid="pgen.1004952.ref002">2</xref>]. Genetic and cell biological studies have implicated PINK1 and Parkin as critical elements in mitophagy, a mitochondrial quality control pathway that involves the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal system [<xref ref-type="bibr" rid="pgen.1004952.ref001">1</xref>, <xref ref-type="bibr" rid="pgen.1004952.ref002">2</xref>]. Under basal conditions, PINK1 is processed by mitochondrial proteases and targeted for degradation by the UPS [<xref ref-type="bibr" rid="pgen.1004952.ref001">1</xref>, <xref ref-type="bibr" rid="pgen.1004952.ref002">2</xref>]. Following persistent mitochondrial damage (e.g., treatment with the mitochondrial uncoupling agent CCCP) PINK1 is stabilized and accumulates in an active form on the outer mitochondrial membrane [<xref ref-type="bibr" rid="pgen.1004952.ref001">1</xref>, <xref ref-type="bibr" rid="pgen.1004952.ref002">2</xref>]. Although PINK1 activity is essential for the mitochondrial recruitment of cytoplasmic Parkin and for the subsequent ubiquitin-dependent clearance of damaged mitochondria, the mode of Parkin activation and recruitment has been elusive [<xref ref-type="bibr" rid="pgen.1004952.ref001">1</xref>, <xref ref-type="bibr" rid="pgen.1004952.ref002">2</xref>].</p>
<p>A series of recent papers indicates that PINK1 initiates mitophagy by a two-pronged mechanism involving direct phosphorylation of ubiquitin at serine 65 [<xref ref-type="bibr" rid="pgen.1004952.ref003">3</xref>–<xref ref-type="bibr" rid="pgen.1004952.ref005">5</xref>] and the ubiquitin-like domain (UbL) of Parkin, also, at serine 65 [<xref ref-type="bibr" rid="pgen.1004952.ref006">6</xref>–<xref ref-type="bibr" rid="pgen.1004952.ref008">8</xref>] (<xref ref-type="fig" rid="pgen.1004952.g001">Fig. 1A</xref>, <italic>steps 1–2</italic>). Biochemical and structural analyses of Parkin demonstrated that the unique Parkin domain (UPD):Rcat interface (previously termed RING0:RING2), the repressor element of Parkin (REP):RING1 interface, and potentially the UbL:RING1 interface mediate autoinhibition of Parkin under steady state conditions in the cell [<xref ref-type="bibr" rid="pgen.1004952.ref009">9</xref>–<xref ref-type="bibr" rid="pgen.1004952.ref014">14</xref>]. It is tempting to speculate that PINK1 phosphorylation of the Parkin UbL and/or the binding of phosphorylated ubiquitin releases the autoinhibitory elements to allow E2~Ub binding or facilitates conformational rearrangements to confer E2~Ub discharge, ultimately leading to exposure of an optimally aligned Parkin active site. Although the studies on PINK1 phosphorylation of ubiquitin [<xref ref-type="bibr" rid="pgen.1004952.ref003">3</xref>–<xref ref-type="bibr" rid="pgen.1004952.ref005">5</xref>] and Parkin [<xref ref-type="bibr" rid="pgen.1004952.ref006">6</xref>–<xref ref-type="bibr" rid="pgen.1004952.ref008">8</xref>] suggest a novel mechanism for PINK1 activation of Parkin, the expression of phosphomimetics of ubiquitin and Parkin was insufficient to promote the mitochondrial recruitment of Parkin [<xref ref-type="bibr" rid="pgen.1004952.ref003">3</xref>, <xref ref-type="bibr" rid="pgen.1004952.ref008">8</xref>]. Thus the mechanism underlying PINK1-mediated Parkin recruitment remained a mystery.</p>
<fig id="pgen.1004952.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1004952.g001</object-id>
<label>Figure 1</label>
<caption>
<title>Damage-induced feedforward and positive feedback loops mediate the cellular decision to destroy mitochondria.</title>
<p>(A) In healthy cells the mitochondrial kinase PINK1 is proteolytically processed and degraded by the UPS. Following mitochondrial damage, PINK1 is stabilized and phosphorylates ubiquitin and the Parkin UbL (<italic>step 1</italic>), activating Parkin and promoting the polyubiquitination of mitochondrial outer membrane substrates (<italic>step 2</italic>). The polyubiquitin chains are then phosphorylated by PINK1 (<italic>step 3</italic>) and mediate the recruitment of additional Parkin to the mitochondria (<italic>step 4</italic>). (B) Network motifs in the PINK1-Parkin pathway. Mitochondrial damage inhibits PINK1 degradation, initiating dual coherent feedforward loops in the activation of Parkin and generation of phosphorylated polyubiquitin and a positive feedback loop in Parkin recruitment. (C) Hypothetical graph modeling the relationship between mitochondrial damage signal persistence (brief—<italic>blue line</italic>, and persistent—<italic>red line</italic>) and the accumulation of phosphorylated polyubiquitin chains during the progression towards mitophagy commitment. UPS, ubiquitin-proteasome system.</p>
</caption>
<graphic mimetype="image" xlink:type="simple" position="float" xlink:href="info:doi/10.1371/journal.pgen.1004952.g001"/>
</fig>
<p>In December’s issue of <italic>PLOS Genetics</italic>, Shiba-Fukushima et al. provide compelling data indicating that PINK1 directly phosphorylates polyubiquitin chains to mediate the mitochondrial recruitment and activation of Parkin (<xref ref-type="fig" rid="pgen.1004952.g001">Fig. 1A</xref>, <italic>steps 3–4</italic>) [<xref ref-type="bibr" rid="pgen.1004952.ref015">15</xref>]. In vitro, affinity purified Parkin from cells bound purified polyubiquitin chains phosphorylated by recombinant PINK1 with a preference for long K63-linked polyubiquitin over K48-linked polyubiquitin chains, although this preference was not recapitulated with Parkin purified from bacteria. To simulate mitochondrial linked polyubiquitin chains, the authors expressed four tandem copies of ubiquitin G76V fused to the mitochondrial targeting sequence of Tom70 [<xref ref-type="bibr" rid="pgen.1004952.ref015">15</xref>]. Phosphomimetic (S65E) versions of the tandem polyubiquitin chains were bound by Parkin through its RING1-BRcat domains (previously termed RING1:IBR) and were able to promote stable mitochondrial association of Parkin even in the absence of mitochondrial damage [<xref ref-type="bibr" rid="pgen.1004952.ref015">15</xref>]. Both cytosolic phosphomimetic ubiquitin and mitochondrially targeted phosphomimetic tandem polyubiquitin chains were sufficient to activate Parkin, as evidenced by increased Parkin C431S-ubiquitin oxyester formation, but only when the Parkin UbL phosphomimetic was used [<xref ref-type="bibr" rid="pgen.1004952.ref015">15</xref>]. To further understand the physiological importance of their findings, Shiba-Fukushima et al. employed PINK1-/- and Parkin -/- <italic>Drosophila</italic> models, which are associated with severe mitochondrial swelling and matrix disorganization and age-dependent motor defects. Strikingly, the expression of mitochondrially targeted phosphomimetic tandem polyubiquitin chains significantly improve both mitochondrial morphology and motor function in PINK1-/- flies, with little effect on mitochondrial morphology in Parkin -/- flies [<xref ref-type="bibr" rid="pgen.1004952.ref015">15</xref>]. These results are in excellent agreement with a recent publication that employed quantitative proteomics to study PINK1-stimulated Parkin polyubiquitination [<xref ref-type="bibr" rid="pgen.1004952.ref016">16</xref>]. Together, these two publications [<xref ref-type="bibr" rid="pgen.1004952.ref015">15</xref>, <xref ref-type="bibr" rid="pgen.1004952.ref016">16</xref>] suggest that PINK1 phosphorylation of polyubiquitin is the rate-limiting event required for the mitochondrial recruitment, and potentially also the activation, of Parkin.</p>
<p>The destruction of mitochondria represents an irreversible cellular decision with significant consequences for cellular physiology. The emerging data support a model in which the decision to degrade damaged mitochondria is controlled by dual coherent feedforward loops that precede a positive feedback loop (<xref ref-type="fig" rid="pgen.1004952.g001">Fig. 1B</xref>). In a feedfoward loop, two input factors, one of which controls the other, jointly regulate a third target factor. In the PINK1-Parkin pathway, the first feedforward loop mediates maximal activation of Parkin by PINK1 phosphorylation of the Parkin UbL and of ubiquitin. The second feedforward loop involves the generation of mitochondrial polyubiquitin chains by PINK1-activated Parkin, and/or another mitochondrial E3 ligase, and their subsequent phosphorylation by PINK1. These phosphorylated polyubiquitin chains appear to be capable of initiating a self-propagating positive feedback loop, recruiting Parkin to the mitochondria and presumably stimulating polyubiquitination of mitochondrial substrates, which can then be phosphorylated by PINK1 and recruit additional Parkin. The organization of these network motifs predicts beneficial features with respect to the decision to degrade mitochondria, including an initial delay period and a mechanism to detect the persistence of mitochondrial damage (<xref ref-type="fig" rid="pgen.1004952.g001">Fig. 1C</xref>). During the delay period (i.e., low levels of phosphorylated polyubiquitin), the decision to commit to mitophagy would be rapidly reversible, providing a useful means of filtering out brief, low levels of mitochondrial damage signals and preventing unwarranted mitochondrial destruction (<xref ref-type="fig" rid="pgen.1004952.g001">Fig. 1C</xref>, <italic>blue line</italic>). Only a persistent damage stimulus that overcomes a specific threshold would be sufficient to initiate the positive feedback loop and commit mitochondria for mitophagy (<xref ref-type="fig" rid="pgen.1004952.g001">Fig. 1C</xref>, <italic>red line</italic>). The actions of putative unidentified ubiquitin and Parkin UbL phosphatases, or of mitochondrial deubiquitinating enzymes USP30 [<xref ref-type="bibr" rid="pgen.1004952.ref017">17</xref>], USP15 [<xref ref-type="bibr" rid="pgen.1004952.ref018">18</xref>], or USP8 [<xref ref-type="bibr" rid="pgen.1004952.ref019">19</xref>], which antagonize Parkin-mediated polyubiquitination, would be predicted to regulate the extent of the delay period and the precise commitment threshold. Interestingly, USP30 has been reported to be targeted for UPS degradation by Parkin [<xref ref-type="bibr" rid="pgen.1004952.ref017">17</xref>], providing an elegant mechanism to gradually reduce the magnitude of UPS30’s influence during persistent mitochondrial damage.</p>
<p>The new study from Shiba-Fukushima et al. [<xref ref-type="bibr" rid="pgen.1004952.ref015">15</xref>] contributes an intriguing model for the role of PINK1 in Parkin recruitment to damaged mitochondria and raises several interesting questions for future investigation. Is an unidentified Parkin UbL and/or ubiquitin phosphatase involved in mitochondrial quality control? The mitochondrial phosphatase PGAM5, which functions downstream of PINK1 [<xref ref-type="bibr" rid="pgen.1004952.ref020">20</xref>], is a logical candidate. If polyubiquitination induces the proteasomal degradation of tagged substrates, how does the phospho-polyubiquitin mitochondrial signal persist, are they shielded by phospho-polyubiquitin binding domain-containing proteins or not efficiently recognized by the proteasome? Does Parkin self-association [<xref ref-type="bibr" rid="pgen.1004952.ref021">21</xref>] amplify the feedforward loop? How is the binding and exchange of substrates, phospho-polyubiquitin chains and/or phospho-ubiquitin by Parkin coordinated to control the timing of substrate degradation? Finally, it will be imperative to determine the therapeutic potential of small molecule mimetics of phosphorylated ubiquitin (or Parkin UbL) and regulators of the PINK1-Parkin mitochondrial quality control pathway in the search for cures of idiopathic Parkinson’s disease.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pgen.1004952.ref001">
<label>1</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Narendra</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Youle</surname> <given-names>R</given-names></name> (<year>2012</year>) <article-title>Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism</article-title>. <source>Cold Spring Harb Perspect Biol</source> <volume>4</volume>: <fpage>a011338</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/cshperspect.a011338" xlink:type="simple">10.1101/cshperspect.a011338</ext-link></comment> <object-id pub-id-type="pmid">23125018</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref002">
<label>2</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Winklhofer</surname> <given-names>KF</given-names></name> (<year>2014</year>) <article-title>Parkin and mitochondrial quality control: toward assembling the puzzle</article-title>. <source>Trends Cell Biol</source> <volume>24</volume>: <fpage>332</fpage>–<lpage>341</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tcb.2014.01.001" xlink:type="simple">10.1016/j.tcb.2014.01.001</ext-link></comment> <object-id pub-id-type="pmid">24485851</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref003">
<label>3</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Koyano</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Okatsu</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kosako</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tamura</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Go</surname> <given-names>E</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Ubiquitin is phosphorylated by PINK1 to activate parkin</article-title>. <source>Nature</source> <volume>510</volume>: <fpage>162</fpage>–<lpage>166</lpage>. <object-id pub-id-type="pmid">24784582</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref004">
<label>4</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Kazlauskaite</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kondapalli</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gourlay</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Campbell</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Ritorto</surname> <given-names>MS</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65</article-title>. <source>Biochem J</source> <volume>460</volume>: <fpage>127</fpage>–<lpage>139</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1042/BJ20140334" xlink:type="simple">10.1042/BJ20140334</ext-link></comment> <object-id pub-id-type="pmid">24660806</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref005">
<label>5</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Kane</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Lazarou</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fogel</surname> <given-names>AI</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yamano</surname> <given-names>K</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity</article-title>. <source>J Cell Biol</source> <volume>205</volume>: <fpage>143</fpage>–<lpage>153</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1083/jcb.201402104" xlink:type="simple">10.1083/jcb.201402104</ext-link></comment> <object-id pub-id-type="pmid">24751536</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref006">
<label>6</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Iguchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kujuro</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Okatsu</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Koyano</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kosako</surname> <given-names>H</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation</article-title>. <source>J Biol Chem</source> <volume>288</volume>: <fpage>22019</fpage>–<lpage>22032</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M113.467530" xlink:type="simple">10.1074/jbc.M113.467530</ext-link></comment> <object-id pub-id-type="pmid">23754282</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref007">
<label>7</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Kondapalli</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kazlauskaite</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Woodroof</surname> <given-names>HI</given-names></name>, <name name-style="western"><surname>Campbell</surname> <given-names>DG</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65</article-title>. <source>Open Biol</source> <volume>2</volume>: <fpage>120080</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1098/rsob.120080" xlink:type="simple">10.1098/rsob.120080</ext-link></comment> <object-id pub-id-type="pmid">22724072</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref008">
<label>8</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Shiba-Fukushima</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Imai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yoshida</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ishihama</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kanao</surname> <given-names>T</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy</article-title>. <source>Sci Rep</source> <volume>2</volume>: <fpage>1002</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/srep01002" xlink:type="simple">10.1038/srep01002</ext-link></comment> <object-id pub-id-type="pmid">23256036</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref009">
<label>9</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Chaugule</surname> <given-names>VK</given-names></name>, <name name-style="western"><surname>Burchell</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Barber</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Sidhu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Leslie</surname> <given-names>SJ</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Autoregulation of Parkin activity through its ubiquitin-like domain</article-title>. <source>EMBO J</source> <volume>30</volume>: <fpage>2853</fpage>–<lpage>2867</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/emboj.2011.204" xlink:type="simple">10.1038/emboj.2011.204</ext-link></comment> <object-id pub-id-type="pmid">21694720</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref010">
<label>10</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Riley</surname> <given-names>BE</given-names></name>, <name name-style="western"><surname>Lougheed</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Callaway</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Velasquez</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Brecht</surname> <given-names>E</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases</article-title>. <source>Nat Commun</source> <volume>4</volume>: <fpage>1982</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms2982" xlink:type="simple">10.1038/ncomms2982</ext-link></comment> <object-id pub-id-type="pmid">23770887</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref011">
<label>11</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Spratt</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Martinez-Torres</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Noh</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Mercier</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Manczyk</surname> <given-names>N</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>A molecular explanation for the recessive nature of parkin-linked Parkinson's disease</article-title>. <source>Nat Commun</source> <volume>4</volume>: <fpage>1983</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms2983" xlink:type="simple">10.1038/ncomms2983</ext-link></comment> <object-id pub-id-type="pmid">23770917</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref012">
<label>12</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Spratt</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Walden</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Shaw</surname> <given-names>GS</given-names></name> (<year>2014</year>) <article-title>RBR E3 ubiquitin ligases: new structures, new insights, new questions</article-title>. <source>Biochem J</source> <volume>458</volume>: <fpage>421</fpage>–<lpage>437</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1042/BJ20140006" xlink:type="simple">10.1042/BJ20140006</ext-link></comment> <object-id pub-id-type="pmid">24576094</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref013">
<label>13</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Trempe</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Sauve</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Grenier</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Seirafi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>MY</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Structure of parkin reveals mechanisms for ubiquitin ligase activation</article-title>. <source>Science</source> <volume>340</volume>: <fpage>1451</fpage>–<lpage>1455</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1237908" xlink:type="simple">10.1126/science.1237908</ext-link></comment> <object-id pub-id-type="pmid">23661642</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref014">
<label>14</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Wauer</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Komander</surname> <given-names>D</given-names></name> (<year>2013</year>) <article-title>Structure of the human Parkin ligase domain in an autoinhibited state</article-title>. <source>EMBO J</source> <volume>32</volume>: <fpage>2099</fpage>–<lpage>2112</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/emboj.2013.125" xlink:type="simple">10.1038/emboj.2013.125</ext-link></comment> <object-id pub-id-type="pmid">23727886</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref015">
<label>15</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Shiba-Fukushima</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Arano</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Inoshita</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yoshida</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Phosphorylation of Mitochondrial Polyubiquitin by PINK1 Promotes Parkin Mitochondrial Tethering</article-title>. <source>PLoS Genet</source> <volume>10</volume>: <fpage>e1004861</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1004861" xlink:type="simple">10.1371/journal.pgen.1004861</ext-link></comment> <object-id pub-id-type="pmid">25474007</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref016">
<label>16</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Ordureau</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sarraf</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Duda</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Heo</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Jedrychowski</surname> <given-names>MP</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Quantitative Proteomics Reveal a Feedforward Mechanism for Mitochondrial PARKIN Translocation and Ubiquitin Chain Synthesis</article-title>. <source>Mol Cell</source> <volume>56</volume>: <fpage>360</fpage>–<lpage>375</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molcel.2014.09.007" xlink:type="simple">10.1016/j.molcel.2014.09.007</ext-link></comment> <object-id pub-id-type="pmid">25284222</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref017">
<label>17</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Bingol</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Tea</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Phu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Reichelt</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bakalarski</surname> <given-names>CE</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy</article-title>. <source>Nature</source> <volume>510</volume>: <fpage>370</fpage>–<lpage>375</lpage>. <object-id pub-id-type="pmid">24896179</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref018">
<label>18</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Cornelissen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Haddad</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wauters</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Van Humbeeck</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mandemakers</surname> <given-names>W</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy</article-title>. <source>Hum Mol Genet</source> <volume>23</volume>: <fpage>5227</fpage>–<lpage>5242</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/hmg/ddu244" xlink:type="simple">10.1093/hmg/ddu244</ext-link></comment> <object-id pub-id-type="pmid">24852371</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref019">
<label>19</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Durcan</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>MY</given-names></name>, <name name-style="western"><surname>Perusse</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Dashti</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Aguileta</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin</article-title>. <source>EMBO J</source> <volume>33</volume>: <fpage>2473</fpage>–<lpage>2491</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15252/embj.201489729" xlink:type="simple">10.15252/embj.201489729</ext-link></comment> <object-id pub-id-type="pmid">25216678</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref020">
<label>20</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Imai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kanao</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sawada</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kobayashi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Moriwaki</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila</article-title>. <source>PLoS Genet</source> <volume>6</volume>: <fpage>e1001229</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1001229" xlink:type="simple">10.1371/journal.pgen.1001229</ext-link></comment> <object-id pub-id-type="pmid">21151955</object-id></mixed-citation>
</ref>
<ref id="pgen.1004952.ref021">
<label>21</label>
<mixed-citation xlink:type="simple" publication-type="journal">
<name name-style="western"><surname>Lazarou</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Narendra</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Tekle</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Banerjee</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding</article-title>. <source>J Cell Biol</source> <volume>200</volume>: <fpage>163</fpage>–<lpage>172</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1083/jcb.201210111" xlink:type="simple">10.1083/jcb.201210111</ext-link></comment> <object-id pub-id-type="pmid">23319602</object-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>